COVID-19 in patients with psoriasis: A Latin American case series
Isabela Campo-Slebi, MD,
María Fernanda Meza-Corso, MD,
Paola Cárdenas, MD,
Juan Raúl Castro-Ayarza, MD,
Cesar González, MD,
Carolina Cortés, MD,
Manuel Franco, MD,
Fernando Valenzuela, MD
Affiliations
Isabela Campo-Slebi, MD
Medical Department, Clínica del Country, Bogotá, Colombia; Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia
María Fernanda Meza-Corso, MD
Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia; Medicine Faculty, Universidad Nacional de Colombia, Bogotá, Colombia
Paola Cárdenas, MD
Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia; Medicine Faculty, Dermatologist Universidad Nacional de Colombia, Bogotá, Colombia
Juan Raúl Castro-Ayarza, MD
Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia; Medicine Faculty, Dermatologist Universidad Nacional de Colombia, Bogotá, Colombia; Medicine Faculty, Hospital Universitario Nacional de Colombia, Bogotá, Colombia; Correspondence to: Juan Raúl Castro-Ayarza, MD, Dermatology, Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Carrera 16A # 82-46 Cons: 303, Bogotá 110121, Colombia
Cesar González, MD
Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia; Medicine Faculty, Dermatologist Universidad El Bosque, Bogotá, Colombia
Carolina Cortés, MD
Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia; Dermatology Department, Hospital Universitario de La Samaritana, Bogotá, Colombia
Manuel Franco, MD
Colombian group of psoriasis and psoriatic arthritis (COLPSOR), Bogotá, Colombia; Medicine Faculty, Dermatologist Universidad El Bosque, Bogotá, Colombia
Fernando Valenzuela, MD
Medicine Faculty, Universidad de Chile, Santiago, Chile